The anti-obesity effect of the absence of iNOS is probably due to changes in pathways promoting the differentiation of brown fat cells, and changes in genes involved in brown fat function, such as Sirt1, Sirt-3 and Pgc-1α. This evidence concerns the gene PPARGC1A and obesity due to melanocortin 4 receptor deficiency.